27588139|t|Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer
27588139|a|Recently, kinesin motor proteins have been focused on as targets for cancer therapy. Kinesins are microtubule -based motor proteins that mediate diverse functions within the cell, including the transport of vesicles, organelles, chromosomes and protein complexes, as well as the movement of microtubules. In the current study, the expression of kinesin family member 18A (KIF18A), a member of kinesin superfamily, was investigated in breast cancer using immunohistochemistry, and its effect on breast cancer prognosis was examined. KIF18A expression level was significantly associated with lymph node metastasis (P=0.047). In patients with high levels of KIF18A expression, survival was significantly poorer compared to patients with low levels of KIF18A expression (disease-free survival, P=0.030). Multivariate analysis revealed that venous invasion (hazard ratio, 9.22; 95% confidence interval, 3.90-23.66; P<0.001) and KIF18A expression (hazard ratio, 3.20; 95% confidence interval, 1.34-6.09; P=0.010) were independent predictive factors for lymph node metastasis. KIF18A may be a useful predictive marker for lymph node metastasis in breast cancer, which could facilitate curative adjuvant treatment.
27588139	0	19	Clinicopathological	T091	C0030667
27588139	33	58	kinesin family member 18A	T116,T126	C1610793
27588139	59	69	expression	T045	C1171362
27588139	73	95	invasive breast cancer	T191	C0853879
27588139	106	113	kinesin	T116,T126	C0085139
27588139	114	128	motor proteins	T116,T123	C1720835
27588139	153	160	targets	T169	C1521840
27588139	165	179	cancer therapy	T061	C0920425
27588139	181	189	Kinesins	T116,T126	C0085139
27588139	194	205	microtubule	T116,T123	C0026042
27588139	213	227	motor proteins	T116,T123	C1720835
27588139	241	258	diverse functions	T169	C0542341
27588139	270	274	cell	T025	C0007634
27588139	290	299	transport	T043	C0005528
27588139	303	311	vesicles	T026	C1622418
27588139	313	323	organelles	T026	C0029219
27588139	325	336	chromosomes	T026	C0008633
27588139	341	358	protein complexes	T116,T123	C1180347
27588139	375	399	movement of microtubules	T043	C1156033
27588139	427	437	expression	T045	C1171362
27588139	441	466	kinesin family member 18A	T116,T126	C1610793
27588139	468	474	KIF18A	T116,T126	C1610793
27588139	479	508	member of kinesin superfamily	T116,T126	C0085139
27588139	514	526	investigated	T169	C1292732
27588139	530	543	breast cancer	T191	C0006142
27588139	550	570	immunohistochemistry	T060	C0021044
27588139	590	603	breast cancer	T191	C0006142
27588139	628	634	KIF18A	T116,T126	C1610793
27588139	635	651	expression level	T081	C3244092
27588139	670	685	associated with	T080	C0332281
27588139	686	707	lymph node metastasis	T191	C0686619
27588139	722	730	patients	T101	C0030705
27588139	751	757	KIF18A	T116,T126	C1610793
27588139	758	768	expression	T045	C1171362
27588139	770	778	survival	T052	C0038952
27588139	816	824	patients	T101	C0030705
27588139	844	850	KIF18A	T116,T126	C1610793
27588139	851	861	expression	T045	C1171362
27588139	863	884	disease-free survival	T081	C0242793
27588139	896	917	Multivariate analysis	T081	C0026777
27588139	932	947	venous invasion	T033	C1710625
27588139	949	961	hazard ratio	T081	C2985465
27588139	973	992	confidence interval	T081	C0009667
27588139	1019	1025	KIF18A	T116,T126	C1610793
27588139	1026	1036	expression	T045	C1171362
27588139	1038	1050	hazard ratio	T081	C2985465
27588139	1062	1081	confidence interval	T081	C0009667
27588139	1120	1138	predictive factors	T170	C0683956
27588139	1143	1164	lymph node metastasis	T191	C0686619
27588139	1166	1172	KIF18A	T116,T126	C1610793
27588139	1189	1199	predictive	T170	C0683956
27588139	1200	1206	marker	T201	C0005516
27588139	1211	1232	lymph node metastasis	T191	C0686619
27588139	1236	1249	breast cancer	T191	C0006142
27588139	1274	1291	curative adjuvant	T033	C3846124
27588139	1292	1301	treatment	T061	C0087111